Antibe Therapeutics Inc(Pre-Merger) ATBPF

When do we get an actual release with timelines?

[Nick80]

Thank you Dan for providing an update.

I was looking for some more responsibility where shareholders are provided with more concrete information/ timelines!

 

1. 'coming quarters' for the IBD candidate 

2. Potentially Extend IP Protection 

3. otenaproxesul in acute pain indications, with initial clinical studies expected to begin in the upcoming quarter. 

4. The Company is investigating alternative dosing regimens as a potential path forward for chronic indications.

5. given the relatively short trials required, we foresee a faster path to market than originally envisaged with our chronic pain program 

All this leads me to think that management is uncertain about their future and pipeline and is shifting gears as need be to have something to work on with the 60mio in the bank and to keep investors interested to fund their paychecks. This has thrown the company back years. I wouldn't be suprised if it is half a decade, if not longer to materialize anything meaningful, if at all.